Infectious Disease and Microbiology – Loa loa

Overview

Loa loa is a filarial nematode that causes loiasis, also known as African eye worm disease. Infection is endemic in parts of Central and West Africa and is transmitted to humans by the bite of infected Chrysops deer flies.

Most infected individuals remain asymptomatic. Symptomatic disease classically produces transient angioedematous swellings called Calabar swellings and migration of an adult worm across the subconjunctival tissues of the eye.

Classification

Genus: Loa

Species: Loa loa

Type: Filarial nematode

Disease: Loiasis

Common name: African eye worm

Microbiologic Characteristics

L. loa is a:

• Tissue-dwelling filarial nematode

• Parasite transmitted by an arthropod vector

• Cause of chronic subcutaneous infection

• Producer of circulating microfilariae

Adult worms migrate through the subcutaneous tissues, whereas microfilariae circulate in the peripheral bloodstream.

Vector

The vector is an infected:

Chrysops deer fly

These flies are also called:

Deer flies or mango flies

Transmission occurs when an infected fly takes a blood meal and introduces infective larvae into the skin.

Transmission Cycle

Infected Chrysops fly bites human

↓

Infective larvae enter the skin

↓

Larvae mature into adult worms

↓

Adult worms migrate through subcutaneous tissues

↓

Females release microfilariae

↓

Microfilariae circulate in peripheral blood

↓

Another deer fly ingests microfilariae

Incubation and Development

Microfilariae may become detectable in peripheral blood several months after infection.

The source describes approximately:

4 months

as an early point at which microfilaremia or symptoms may appear.

However, symptomatic loiasis frequently develops only after:

Several years

This prolonged course reflects the chronic nature of filarial infection.

Epidemiology

Loiasis occurs primarily in:

Central and West Africa

particularly in forested regions where the Chrysops vector is present.

The source estimates that millions of people may be infected in endemic regions.

Clinical Infection

The disease caused by L. loa is:

Loiasis

Most infected people are:

Asymptomatic

When manifestations occur, they primarily result from migration of adult worms through subcutaneous tissues and the host inflammatory response.

Calabar Swellings

Classic Manifestation

One of the most characteristic findings is:

Calabar swelling

These are transient, localized areas of subcutaneous edema caused by the inflammatory response associated with migrating adult worms.

Clinical Features

Calabar swellings may:

• Appear suddenly

• Occur on different parts of the body

• Produce localized discomfort

• Cause pruritus

• Cause localized pain

• Persist temporarily and then resolve

• Recur at another location

The extremities are commonly affected.

Pathogenesis

Adult worm migrates through tissue

↓

Local inflammatory/hypersensitivity response

↓

Transient localized edema

↓

Calabar swelling

Eye Worm

Subconjunctival Migration

Another classic manifestation is migration of an:

Adult Loa loa worm across the conjunctiva

The worm may be directly visible moving beneath the conjunctival surface.

This striking finding accounts for the name:

African eye worm

Clinical Manifestations

Subconjunctival migration can cause:

• Foreign-body sensation

• Eye irritation

• Conjunctival inflammation

• Lacrimation

• Discomfort

Although dramatic, the worm’s passage across the eye is usually transient.

High-Yield Clinical Pattern

Patient from Central or West Africa

• ●

Recurrent transient localized swelling

• ●

Visible worm migrating across the conjunctiva

→ Think Loa loa

→ Diagnosis: Loiasis

Microfilariae

Diurnal Periodicity

A particularly important characteristic is:

Diurnal periodicity

Loa loa microfilariae are most abundant in peripheral blood during the:

Daytime

This corresponds with the daytime feeding behavior of the Chrysops vector.

Diagnostic Implication

Blood should therefore be collected during:

Daylight hours

Traditionally, collection around the middle of the day improves the likelihood of detecting microfilariae.

This is a major examination clue.

Diagnosis

Peripheral Blood Smear

The classic diagnostic method is:

Detection of microfilariae in peripheral blood

Because of diurnal periodicity:

Obtain a daytime blood sample.

Thick and thin blood smears can be examined microscopically.

Direct Visualization

Diagnosis may also be established by:

Visualizing an adult worm beneath the conjunctiva

This is a highly characteristic finding in the appropriate epidemiologic setting.

Tissue Examination

The parasite may occasionally be identified in:

Subcutaneous tissue

especially when a migrating adult worm is removed.

Serology

The source also lists:

Serologic testing

Serology can support the diagnosis but may have limitations in distinguishing among filarial infections, particularly in endemic areas.

Treatment

Diethylcarbamazine

The source identifies:

Diethylcarbamazine (DEC)

as the principal treatment for loiasis.

DEC has activity against:

Microfilariae

and can also have activity against:

Adult worms

Therefore, it has the potential to provide definitive treatment.

Major Treatment Danger

High Microfilarial Burden

Treatment of loiasis requires special caution because rapid killing of large numbers of microfilariae can provoke a severe inflammatory reaction.

This is particularly important in patients with:

High-grade microfilaremia

Encephalopathy

A major complication of treatment can be:

Severe encephalopathy/meningoencephalitis

which may be life-threatening.

The source particularly warns about careful supervision when microfilarial density exceeds approximately:

2,000 microfilariae/mL

The risk becomes especially concerning as microfilarial burden increases.

Treatment Principle

Before administering potent microfilaricidal therapy:

Diagnose loiasis

↓

Measure the peripheral microfilarial burden

↓

Assess risk of treatment-associated neurologic complications

↓

Select and administer therapy under appropriate supervision

This is one of the most important clinical principles in managing Loa loa infection.

Additional Treatment

The source lists:

• Ivermectin

• Albendazole

However, ivermectin requires particular caution because patients with very high Loa loa microfilaremia can develop severe or fatal neurologic adverse events following rapid microfilarial killing.

Albendazole has a slower effect on microfilarial levels and has been used in selected situations.

Surgical Removal

When an adult worm is accessible, such as beneath the conjunctiva, it may be:

Surgically extracted

Removal can relieve local symptoms but does not necessarily eliminate other adult worms or circulating microfilariae elsewhere in the body.

Loa loa and Onchocerciasis Treatment

A particularly important practical association is that Loa loa co-infection can complicate treatment programs for:

Onchocerca volvulus

Ivermectin is widely used against onchocerciasis, but a patient with heavy Loa loa microfilaremia may be at risk for severe neurologic reactions after ivermectin.

Therefore, in areas where both parasites occur:

Consider Loa loa burden before ivermectin treatment.

Loa loa vs. Onchocerca volvulus

Loa loa

→ Chrysops deer fly

→ Daytime microfilariae in blood

→ Calabar swellings

→ Eye worm crosses conjunctiva

→ DEC is an important treatment

→ High microfilarial burden creates treatment-related encephalopathy risk

Onchocerca volvulus

→ Blackfly (Simulium)

→ Microfilariae primarily in skin, not peripheral blood

→ Subcutaneous nodules

→ Dermatitis

→ Ocular disease and river blindness

→ Ivermectin is central to treatment

Loa loa vs. Wuchereria bancrofti

Loa loa

→ Chrysops deer fly

→ Diurnal blood periodicity

→ Calabar swelling

→ Subconjunctival adult worm

Wuchereria bancrofti

→ Mosquito vector

→ Classically nocturnal blood periodicity

→ Lymphatic filariasis

→ Lymphedema and elephantiasis

High-Yield Diagnostic Pattern

Central/West Africa

• ●

Chrysops deer fly exposure

• ●

Calabar swellings

• ●

Subconjunctival migrating worm

• ●

Diurnally periodic microfilariae in peripheral blood

→ Loa loa

Exam Essentials

Organism: Loa loa

Type: Filarial nematode

Disease: Loiasis

Common name: African eye worm

Geography: Central and West Africa

Vector: Chrysops deer fly

Major reservoir/host: Humans are important hosts in endemic transmission

Adult worms: Migrate through subcutaneous tissues

Classic swelling: Calabar swelling

Classic ocular manifestation: Adult worm crossing the subconjunctiva

Microfilariae: Circulate in peripheral blood

Periodicity: Diurnal

Best classic blood sampling: Daytime

Diagnosis: Peripheral blood smear, direct visualization/removal of adult worm, supportive serology

Primary source treatment: Diethylcarbamazine (DEC)

Additional source treatments: Ivermectin and albendazole

Major treatment danger: Encephalopathy with high microfilarial burden

Important ivermectin issue: Heavy Loa loa microfilaremia increases the risk of severe neurologic adverse reactions

Key clinical pearl: The classic triad for Loa loa is Central/West African exposure, recurrent Calabar swellings, and a migrating subconjunctival “eye worm.” Microfilariae demonstrate diurnal periodicity, so diagnostic blood should be obtained during the daytime. Always consider the microfilarial burden before microfilaricidal treatment because heavily infected patients can develop life-threatening encephalopathy.

Infectious Disease and Microbiology – Linguatula serrata

Overview

Linguatula serrata is a pentastomid parasite, commonly called the tongue worm, that can occasionally infect humans. Human infection is known as linguatuliasis.

The parasite primarily infects animals, while humans can become accidental hosts. One of its classic clinical presentations is infestation of the nasopharynx, producing a syndrome known as halzoun or marrara syndrome.

Taxonomy

Genus: Linguatula

Species: Linguatula serrata

The source contains the spelling “L. serrate”; the correct species name is:

L. serrata

Microbiologic Characteristics

L. serrata is a:

• Pentastomid parasite

• Commonly called a tongue worm

• Obligate parasite of vertebrate hosts

• Cause of rare zoonotic human infection

Despite the traditional term “tongue worm,” pentastomids are not true helminthic worms in the conventional taxonomic sense. They are highly specialized parasitic arthropods related to crustaceans.

Morphology

The adult parasite has an elongated, flattened appearance that resembles a tongue, accounting for the name:

Tongue worm

The life cycle includes:

Egg → larva/nymph → adult

The nymphal stage is particularly important in human infection.

Incubation Period

The incubation period is:

Not clearly established

For nasopharyngeal disease, symptoms can develop after ingestion of infective stages in contaminated or inadequately prepared animal tissues.

Epidemiology

Human linguatuliasis is uncommon but has been reported more frequently in:

• Middle Eastern regions

• Africa

Cases can also occur elsewhere where the parasite’s animal life cycle is maintained.

Animal Hosts

The parasite has a zoonotic life cycle involving various animals.

The source broadly associates pentastomid parasites with:

• Reptiles

• Birds

• Mammals

For L. serrata specifically, dogs and other canids are particularly important definitive hosts, while herbivorous mammals can serve as intermediate hosts.

Transmission to Humans

Human infection can occur through ingestion of:

Raw or inadequately cooked infected animal tissues

particularly viscera containing nymphal stages.

Exposure to parasite eggs from material contaminated by infected definitive hosts can also produce visceral infection.

Linguatuliasis

Human disease can be divided broadly into:

Nasopharyngeal linguatuliasis

and

Visceral linguatuliasis

The source particularly emphasizes the nasopharyngeal form.

Nasopharyngeal Linguatuliasis

Halzoun or Marrara Syndrome

The classic clinical syndrome is:

Halzoun

also called:

Marrara syndrome

This occurs when immature/nymphal parasites attach to or migrate within the upper respiratory and pharyngeal mucosa.

Clinical Manifestations

Nymphs may lodge in the:

• Nasopharynx

• Pharynx

• Nasal passages

• Upper airway

They can cause:

• Foreign-body sensation

• Nasal or pharyngeal irritation

• Cough

• Sneezing

• Dysphagia

• Throat discomfort

• Nasal obstruction

• Upper-airway obstruction in severe cases

Pathogenesis

The characteristic sequence is:

Ingestion of infected raw/undercooked viscera

↓

Release of nymphal parasite

↓

Attachment to nasopharyngeal mucosa

↓

Inflammation and mechanical irritation

↓

Halzoun syndrome

Visceral Linguatuliasis

Humans may also function as accidental intermediate hosts.

After ingestion of parasite eggs, larvae can penetrate the intestinal wall and migrate into internal organs, where they develop into nymphal forms.

Potential sites include:

• Liver

• Lymph nodes

• Other visceral tissues

Many visceral infections may remain asymptomatic and be discovered incidentally.

Diagnosis

The source lists:

Histologic examination of biopsy tissue

as an important diagnostic method.

Diagnosis may be established by demonstrating characteristic parasite structures in affected tissue.

Direct Identification

In nasopharyngeal disease, diagnosis may also be possible when the parasite is:

Directly visualized and removed

Identification of the recovered organism can establish the diagnosis.

Imaging

Visceral nymphs may eventually undergo degeneration and calcification.

Therefore, chronic visceral linguatuliasis may occasionally be recognized through:

Calcified lesions on imaging

although imaging findings alone are not necessarily specific.

Treatment

The primary treatment described in the source is:

Surgical or mechanical removal

This is especially appropriate for accessible parasites involving the nasopharynx.

Nasopharyngeal Disease

For halzoun:

Locate parasite

↓

Remove mechanically

↓

Relieve mucosal irritation and obstruction

Symptomatic supportive care can be provided as necessary.

Visceral Disease

Asymptomatic visceral infection may not require intervention when lesions are inaccessible and inactive.

Surgical management may be considered when a localized lesion produces significant symptoms or complications.

Prevention

Prevention centers on interrupting foodborne and zoonotic exposure.

Important measures include:

• Thoroughly cooking animal meat and viscera

• Avoiding consumption of raw infected liver or other organs

• Appropriate food hygiene

• Avoiding contamination of food or water with animal feces or secretions

High-Yield Clinical Pattern

Middle East or Africa

• ●

Consumption of raw/undercooked animal viscera

• ●

Sudden nasopharyngeal irritation or obstruction

• ●

Visible tongue-worm nymph

→ Think Linguatula serrata

→ Halzoun syndrome

Linguatula vs. Other Tissue Parasites

Linguatula serrata

→ Pentastomid/tongue worm

→ Raw animal viscera

→ Nasopharyngeal disease

→ Halzoun syndrome

→ Mechanical removal

Gnathostoma spinigerum

→ Nematode

→ Raw/undercooked fish or other intermediate/paratenic hosts

→ Migratory cutaneous swelling

→ Eosinophilia

→ Possible CNS disease

Fasciola hepatica

→ Trematode

→ Aquatic vegetation

→ Hepatic migration followed by biliary disease

→ Eosinophilia common during acute migration

Exam Essentials

Organism: Linguatula serrata

Source correction: “L. serrate” → L. serrata

Common name: Tongue worm

Type: Pentastomid parasite

Taxonomic note: Pentastomids are specialized parasitic arthropods rather than conventional helminthic worms

Distribution: More frequently reported in the Middle East and Africa

Important definitive hosts: Dogs and other canids

Human role: Accidental host

Important exposure: Raw or undercooked animal viscera

Classic disease: Nasopharyngeal linguatuliasis

Classic syndrome: Halzoun (marrara syndrome)

Major symptoms: Nasopharyngeal irritation, foreign-body sensation and possible obstruction

Other form: Visceral linguatuliasis

Diagnosis: Direct parasite identification or histologic examination

Treatment: Mechanical/surgical removal

Prevention: Thorough cooking of meat and viscera

Key clinical pearl: Think of Linguatula serrata when ingestion of raw or undercooked animal viscera is followed by acute nasopharyngeal irritation, foreign-body sensation, or obstruction. This classic presentation is called halzoun (marrara syndrome), and treatment is primarily mechanical removal of the parasite.

Infectious Disease and Microbiology – Leuconostoc Species

Overview

Leuconostoc species are Gram-positive cocci that are uncommon causes of human disease. They have a worldwide distribution and may be confused in the laboratory with Enterococcus species or viridans group streptococci.

Although isolation may occasionally represent contamination or colonization, recovery of Leuconostoc from blood cultures should be evaluated carefully, particularly because true bacteremia and infective endocarditis can occur.

A particularly important microbiologic feature is their intrinsic resistance to vancomycin.

Important Species

The source lists:

• Leuconostoc citreum

• Leuconostoc lactis

• Leuconostoc mesenteroides

• Leuconostoc paramesenteroides

• Other Leuconostoc species

Taxonomy within this group has changed over time, so some organisms found in older literature have subsequently been reassigned.

Microbiologic Characteristics

Leuconostoc species are generally:

• Gram-positive cocci

• Facultatively anaerobic rather than strictly anaerobic

• Catalase-negative

• Non-spore-forming

• Lactic acid-producing organisms

Their appearance and biochemical characteristics can lead to confusion with other catalase-negative Gram-positive cocci.

Laboratory Identification

Leuconostoc may be mistaken for:

Enterococcus species

or:

Viridans group streptococci

Accurate identification is clinically important because the antimicrobial susceptibility pattern differs substantially from that of many other Gram-positive cocci.

Vancomycin Resistance

Major High-Yield Feature

The most important antimicrobial characteristic is:

Intrinsic vancomycin resistance

Therefore:

Gram-positive coccus

• ●

Looks like Enterococcus or viridans streptococcus

• ●

Vancomycin resistant

→ Consider Leuconostoc

Clinical Importance of Vancomycin Resistance

Vancomycin is commonly used empirically for serious Gram-positive infections.

However:

Leuconostoc → intrinsically resistant to vancomycin

Thus, failure to identify the organism correctly can lead to inappropriate antimicrobial treatment.

Incubation Period

The incubation period is:

Unknown

A defined incubation period is generally not clinically useful because invasive disease is rare and frequently occurs opportunistically in patients with significant underlying risk factors.

Epidemiology

Leuconostoc species have a:

Worldwide distribution

They are widely encountered in nature and are particularly associated with:

• Plants

• Vegetables

• Fermented foods

• Dairy and food-production environments

Human invasive infection remains uncommon.

Clinical Significance

The source notes that the clinical significance of Leuconostoc species has historically been uncertain.

Isolation may sometimes represent:

Contamination

However, recovery from a normally sterile site—particularly the bloodstream—should not automatically be dismissed.

Bacteremia

Leuconostoc species have occasionally caused:

Bacteremia

The source particularly identifies cases involving:

• Newborns

• Immunocompromised patients

Risk Factors for Invasive Infection

Reported invasive disease is more likely in patients with factors such as:

• Immunosuppression

• Severe underlying illness

• Neonatal age

• Prolonged hospitalization

• Intravascular catheters

• Disrupted gastrointestinal barriers

• Previous broad-spectrum antimicrobial exposure

Because cases are rare, these associations should be interpreted in the overall clinical context.

Blood Culture Interpretation

When Leuconostoc is recovered from blood, consider:

Contaminant?

versus:

True bacteremia/endovascular infection?

Evidence favoring genuine infection includes:

• Multiple positive blood cultures

• Persistent bacteremia

• Fever or sepsis

• Immunocompromised state

• Intravascular device

• Evidence of infective endocarditis

Infective Endocarditis

Leuconostoc species are a:

Rare cause of infective endocarditis

Persistent bloodstream isolation should therefore raise concern for an endovascular focus.

Endocarditis Evaluation

Possible findings include:

• Persistent fever

• Repeated positive blood cultures

• New or changing cardiac murmur

• Valvular vegetation

• Embolic manifestations

When clinically indicated, echocardiography may be necessary to investigate for valvular infection.

High-Yield Endocarditis Pattern

Persistent blood cultures with Leuconostoc

• ●

Fever

• ●

Cardiac/endovascular findings

→ Evaluate for infective endocarditis

Do not automatically dismiss the isolate as contamination.

Diagnosis

The principal diagnostic method is:

Culture

Depending on the infection, specimens may include:

• Blood cultures

• Catheter-associated specimens

• Tissue or other normally sterile material

Correct species identification is particularly important because of the organism’s vancomycin resistance.

Treatment

Penicillin or Ampicillin

The source recommends:

Penicillin G

or:

Ampicillin

For severe infections, the source recommends:

High-dose intravenous therapy

Additional Treatment Options

The source lists:

• First-generation cephalosporins

• Clindamycin

• Imipenem

Because invasive Leuconostoc infection is uncommon, treatment should ideally be guided by:

Antimicrobial susceptibility testing

particularly in severe or endovascular disease.

Avoid Vancomycin

A central treatment principle is:

Do not rely on vancomycin for Leuconostoc.

The organism is:

Intrinsically resistant to vancomycin

This is not simply an occasional acquired resistance pattern; it is a characteristic property of the genus.

Mechanism of Vancomycin Resistance

Vancomycin normally binds to the:

D-Ala-D-Ala

terminus of peptidoglycan precursors.

Leuconostoc uses altered cell-wall precursors ending in:

D-Ala-D-Lac

which greatly reduces vancomycin binding.

This provides the basis for its characteristic intrinsic glycopeptide resistance.

Treatment Principle

For clinically significant Leuconostoc infection:

Confirm true infection

↓

Correctly identify the organism

↓

Recognize intrinsic vancomycin resistance

↓

Perform susceptibility testing

↓

Use an active agent such as penicillin/ampicillin when susceptible

↓

Evaluate persistent bacteremia for an endovascular source

Leuconostoc vs. Enterococcus

Leuconostoc

→ Gram-positive coccus

→ Catalase-negative

→ May resemble Enterococcus

→ Rare opportunistic pathogen

→ Intrinsically vancomycin resistant

Enterococcus

→ Gram-positive coccus

→ Catalase-negative

→ Common GI flora

→ Common cause of UTI, bacteremia and endocarditis

→ Vancomycin susceptibility varies; acquired VRE mechanisms are clinically important

The distinction is particularly important when a presumed “enterococcus” demonstrates unexpected vancomycin resistance.

High-Yield Clinical Pattern

Immunocompromised or neonatal patient

• ●

Gram-positive cocci in blood

• ●

Organism resembles Enterococcus/viridans streptococcus

• ●

Vancomycin resistance

→ Think Leuconostoc

Exam Essentials

Genus: Leuconostoc

Important species: L. citreum, L. lactis, L. mesenteroides, L. paramesenteroides

Morphology: Gram-positive cocci

Metabolism: Facultatively anaerobic

Catalase: Negative

Distribution: Worldwide

Incubation: Unknown

Clinical significance: Usually low pathogenicity but capable of invasive disease

Important hosts: Newborns and immunocompromised patients

Major invasive infection: Bacteremia

Endovascular infection: Rare endocarditis

Diagnostic method: Culture

Laboratory confusion: Enterococcus and viridans streptococci

Source treatment: Penicillin G or ampicillin

Severe disease: High-dose IV therapy described in source

Additional source treatments: First-generation cephalosporin, clindamycin, imipenem

Major antimicrobial clue: Intrinsic vancomycin resistance

Resistance mechanism: Cell-wall precursor ending in D-Ala-D-Lac

Key clinical pearl: The classic clue for Leuconostoc is an unusual catalase-negative Gram-positive coccus that resembles Enterococcus or viridans streptococci but is intrinsically resistant to vancomycin. When repeatedly isolated from blood, particularly in a newborn or immunocompromised patient, it should be taken seriously and persistent bacteremia should prompt consideration of endocarditis.

Important Species The source lists: • Leuconostoc citreum

• Leuconostoc lactis

• Leuconostoc mesenteroides

• Leuconostoc paramesenteroides

• Other Leuconostoc species Taxonomy within this group has changed over time, so some organisms found in older literature have subsequently been reassigned.

Microbiologic Characteristics Leuconostoc species are generally: • Gram-positive cocci

• Facultatively anaerobic rather than strictly anaerobic

• Catalase-negative

• Non-spore-forming

• Lactic acid-producing organisms Their appearance and biochemical characteristics can lead to confusion with other catalase-negative Gram-positive cocci.

Laboratory Identification Leuconostoc may be mistaken for: Enterococcus species or: Viridans group streptococci Accurate identification is clinically important because the antimicrobial susceptibility pattern differs substantially from that of many other Gram-positive cocci.

Vancomycin Resistance Major High-Yield Feature The most important antimicrobial characteristic is: Intrinsic vancomycin resistance Therefore: Gram-positive coccus  ●  Looks like Enterococcus or viridans streptococcus  ●  Vancomycin resistant → Consider Leuconostoc

Clinical Importance of Vancomycin Resistance Vancomycin is commonly used empirically for serious Gram-positive infections. However: Leuconostoc → intrinsically resistant to vancomycin Thus, failure to identify the organism correctly can lead to inappropriate antimicrobial treatment.

Incubation Period The incubation period is: Unknown A defined incubation period is generally not clinically useful because invasive disease is rare and frequently occurs opportunistically in patients with significant underlying risk factors.

Epidemiology Leuconostoc species have a: Worldwide distribution They are widely encountered in nature and are particularly associated with: • Plants

• Vegetables

• Fermented foods

• Dairy and food-production environments Human invasive infection remains uncommon.

Clinical Significance The source notes that the clinical significance of Leuconostoc species has historically been uncertain. Isolation may sometimes represent: Contamination However, recovery from a normally sterile site—particularly the bloodstream—should not automatically be dismissed.

Bacteremia Leuconostoc species have occasionally caused: Bacteremia The source particularly identifies cases involving: • Newborns

• Immunocompromised patients

Risk Factors for Invasive Infection Reported invasive disease is more likely in patients with factors such as: • Immunosuppression

• Severe underlying illness

• Neonatal age

• Prolonged hospitalization

• Intravascular catheters

• Disrupted gastrointestinal barriers

• Previous broad-spectrum antimicrobial exposure Because cases are rare, these associations should be interpreted in the overall clinical context.

Blood Culture Interpretation When Leuconostoc is recovered from blood, consider: Contaminant? versus: True bacteremia/endovascular infection? Evidence favoring genuine infection includes: • Multiple positive blood cultures

• Persistent bacteremia

• Fever or sepsis

• Immunocompromised state

• Intravascular device

• Evidence of infective endocarditis

Infective Endocarditis Leuconostoc species are a: Rare cause of infective endocarditis Persistent bloodstream isolation should therefore raise concern for an endovascular focus.

Endocarditis Evaluation Possible findings include: • Persistent fever

• Repeated positive blood cultures

• New or changing cardiac murmur

• Valvular vegetation

• Embolic manifestations When clinically indicated, echocardiography may be necessary to investigate for valvular infection.

High-Yield Endocarditis Pattern Persistent blood cultures with Leuconostoc  ●  Fever  ●  Cardiac/endovascular findings → Evaluate for infective endocarditis Do not automatically dismiss the isolate as contamination.

Diagnosis The principal diagnostic method is: Culture Depending on the infection, specimens may include: • Blood cultures

• Catheter-associated specimens

• Tissue or other normally sterile material Correct species identification is particularly important because of the organism’s vancomycin resistance.

Treatment Penicillin or Ampicillin The source recommends: Penicillin G or: Ampicillin For severe infections, the source recommends: High-dose intravenous therapy

Additional Treatment Options The source lists: • First-generation cephalosporins

• Clindamycin

• Imipenem Because invasive Leuconostoc infection is uncommon, treatment should ideally be guided by: Antimicrobial susceptibility testing particularly in severe or endovascular disease.

Avoid Vancomycin A central treatment principle is: Do not rely on vancomycin for Leuconostoc. The organism is: Intrinsically resistant to vancomycin This is not simply an occasional acquired resistance pattern; it is a characteristic property of the genus.

Mechanism of Vancomycin Resistance Vancomycin normally binds to the: D-Ala-D-Ala terminus of peptidoglycan precursors. Leuconostoc uses altered cell-wall precursors ending in: D-Ala-D-Lac which greatly reduces vancomycin binding. This provides the basis for its characteristic intrinsic glycopeptide resistance.

Treatment Principle For clinically significant Leuconostoc infection: Confirm true infection ↓ Correctly identify the organism ↓ Recognize intrinsic vancomycin resistance ↓ Perform susceptibility testing ↓ Use an active agent such as penicillin/ampicillin when susceptible ↓ Evaluate persistent bacteremia for an endovascular source

Leuconostoc vs. Enterococcus Leuconostoc → Gram-positive coccus

→ Catalase-negative

→ May resemble Enterococcus

→ Rare opportunistic pathogen

→ Intrinsically vancomycin resistant Enterococcus → Gram-positive coccus

→ Catalase-negative

→ Common GI flora

→ Common cause of UTI, bacteremia and endocarditis

→ Vancomycin susceptibility varies; acquired VRE mechanisms are clinically important The distinction is particularly important when a presumed “enterococcus” demonstrates unexpected vancomycin resistance.

High-Yield Clinical Pattern Immunocompromised or neonatal patient  ●  Gram-positive cocci in blood  ●  Organism resembles Enterococcus/viridans streptococcus  ●  Vancomycin resistance → Think Leuconostoc

Exam Essentials Genus: Leuconostoc

Important species: L. citreum, L. lactis, L. mesenteroides, L. paramesenteroides

Morphology: Gram-positive cocci

Metabolism: Facultatively anaerobic

Catalase: Negative

Distribution: Worldwide

Incubation: Unknown

Clinical significance: Usually low pathogenicity but capable of invasive disease

Important hosts: Newborns and immunocompromised patients

Major invasive infection: Bacteremia

Endovascular infection: Rare endocarditis

Diagnostic method: Culture

Laboratory confusion: Enterococcus and viridans streptococci

Source treatment: Penicillin G or ampicillin

Severe disease: High-dose IV therapy described in source

Additional source treatments: First-generation cephalosporin, clindamycin, imipenem

Major antimicrobial clue: Intrinsic vancomycin resistance

Resistance mechanism: Cell-wall precursor ending in D-Ala-D-Lac

Key clinical pearl: The classic clue for Leuconostoc is an unusual catalase-negative Gram-positive coccus that resembles Enterococcus or viridans streptococci but is intrinsically resistant to vancomycin. When repeatedly isolated from blood, particularly in a newborn or immunocompromised patient, it should be taken seriously and persistent bacteremia should prompt consideration of endocarditis.

Infectious Disease and Microbiology – Balamuthia mandrillaris

Overview

Balamuthia mandrillaris is a free-living amoeba that causes a rare but extremely serious central nervous system infection known as granulomatous amebic encephalitis (GAE).

Older literature referred to the organism as a leptomyxid amoeba or “leptomyxid species.” Human infection is uncommon but occurs worldwide and is frequently recognized only at an advanced stage or, historically, postmortem.

⸻

Taxonomy

Current name: Balamuthia mandrillaris

Older terminology: Leptomyxid amoeba

Other medically important free-living amoebae include:

• Naegleria fowleri

• Acanthamoeba species

These organisms can all involve the CNS but differ substantially in their epidemiology and clinical presentation.

⸻

Microbiologic Characteristics

B. mandrillaris is a:

• Free-living amoeba

• Environmental organism

• Protozoan pathogen

• Cause of subacute or chronic granulomatous CNS infection

It exists primarily in:

Trophozoite and cyst forms

Both forms may be demonstrated in infected tissue.

⸻

Environmental Reservoir

Balamuthia is associated particularly with:

Soil and dust

Unlike many conventional infectious agents, it does not require a human host to complete its normal environmental existence.

⸻

Transmission

Human infection is thought to occur primarily when the organism enters through:

Broken or traumatized skin

or possibly through:

Inhalation into the respiratory tract

The organism may subsequently disseminate hematogenously to the:

Central nervous system

⸻

Incubation Period

The precise incubation period is:

Unknown

Disease typically evolves much more slowly than the rapidly progressive meningoencephalitis caused by Naegleria fowleri.

⸻

Epidemiology

Balamuthia mandrillaris infection is:

• Worldwide

• Extremely rare

• Frequently fatal

• Capable of affecting both immunocompromised and immunocompetent individuals

Thus, absence of obvious immunosuppression does not exclude balamuthiasis.

⸻

Granulomatous Amebic Encephalitis

Major Infection

The major manifestation is:

Granulomatous amebic encephalitis (GAE)

This is a progressive inflammatory and destructive infection of the brain.

⸻

Clinical Course

Unlike the explosive course of Naegleria infection, Balamuthia GAE generally has a:

Subacute to chronic course

Symptoms can progress over:

Weeks to months

before severe neurologic deterioration occurs.

⸻

Neurologic Manifestations

Patients may develop:

• Headache

• Fever

• Altered mental status

• Behavioral or personality changes

• Seizures

• Focal neurologic deficits

• Ataxia

• Cranial nerve abnormalities

• Progressive loss of consciousness

The nonspecific presentation can make early diagnosis difficult.

⸻

Cutaneous Disease

An important clue preceding CNS disease can be:

Chronic skin lesions

These may appear before neurologic manifestations and can provide an opportunity for earlier recognition and biopsy.

Skin lesions may occur particularly on the:

• Face

• Central facial region

• Extremities

⸻

High-Yield Clinical Pattern

Chronic unusual skin lesion

Weeks to months later

Progressive neurologic symptoms

Brain lesions/encephalitis

→ Consider Balamuthia mandrillaris

⸻

Diagnosis

The source lists:

CSF evaluation

as part of the diagnostic assessment.

However, definitive diagnosis can be challenging and may require examination of:

• Brain tissue

• Skin biopsy specimens

• CSF

• Other involved tissue

⸻

Immunologic Methods

The source describes:

• Direct immunofluorescence

• Immunoblot

These techniques can help distinguish Balamuthia from other free-living amoebae.

⸻

Molecular Diagnosis

Molecular methods such as:

PCR

can also be used to identify Balamuthia DNA in appropriate clinical specimens.

Because the infection is rare and difficult to recognize, specialized laboratory testing is often necessary.

⸻

Histopathology

Tissue examination may demonstrate:

Amebic trophozoites and cysts

within areas of granulomatous inflammation and tissue destruction.

Recognition of these organisms in brain or skin biopsy material can be critical for diagnosis.

⸻

CSF Findings

CSF abnormalities may resemble other forms of chronic meningoencephalitis and can include:

• Pleocytosis

• Elevated protein

• Reduced or normal glucose

Routine CSF studies alone are generally insufficient to establish the specific diagnosis.

⸻

Imaging

Brain imaging may reveal:

Multiple space-occupying or enhancing lesions

which can mimic:

• Brain tumors

• Abscesses

• Tuberculosis

• Fungal infections

• Other inflammatory CNS diseases

Therefore, the diagnosis requires a high index of suspicion.

⸻

Prognosis

Historically, the prognosis has been:

Very poor

The source notes that many patients were diagnosed:

Postmortem

because of the difficulty of recognizing the infection before advanced neurologic disease developed.

⸻

Treatment

Important Update to the Source

The source states:

“There is no known effective treatment.”

This reflects the historically extremely poor prognosis, but it is too absolute for current clinical understanding.

There is no single reliably curative standardized drug, but rare survivors have been reported after prolonged multidrug therapy.

Management therefore requires expert consultation and combination treatment rather than assuming therapy is universally futile.

⸻

Treatment Principle

Treatment of confirmed or strongly suspected Balamuthia infection generally involves:

Multiple anti-amoebic/antimicrobial agents

used in combination for prolonged periods.

Because the disease is extremely rare, the optimal regimen is not firmly established, and treatment should involve infectious-disease specialists and public-health/reference experts.

⸻

Comparison of Free-Living Amoebae

Balamuthia mandrillaris

→ Soil/dust exposure

→ Skin or respiratory entry

→ Granulomatous amebic encephalitis

→ Subacute/chronic progression

→ Can affect immunocompetent patients

→ Cutaneous lesions may precede CNS disease

Acanthamoeba species

→ Environmental free-living amoeba

→ Keratitis, especially associated with contact lenses

→ Granulomatous amebic encephalitis, particularly in immunocompromised patients

→ Cutaneous disease can occur

Naegleria fowleri

→ Warm freshwater

→ Water enters the nose

→ Migrates through the cribriform plate

→ Primary amebic meningoencephalitis (PAM)

→ Rapid, fulminant disease over days

⸻

High-Yield Balamuthia vs. Naegleria

Balamuthia

→ Soil exposure

→ GAE

→ Weeks to months

→ Possible preceding skin lesion

Naegleria

→ Warm freshwater exposure

→ Nasal entry

→ PAM

→ Rapid progression over days

This difference in tempo is particularly useful diagnostically.

⸻

High-Yield Clinical Pattern

Free-living amoeba

Progressive encephalitis over weeks to months

Possible chronic skin lesion

Granulomatous brain disease

→ Think Balamuthia mandrillaris

⸻

Exam Essentials

Organism: Balamuthia mandrillaris

Older designation: Leptomyxid amoeba

Type: Free-living amoeba

Forms: Trophozoite and cyst

Distribution: Worldwide

Frequency: Extremely rare

Environmental association: Soil and dust

Incubation: Unknown

Possible entry: Skin or respiratory tract

Major disease: Granulomatous amebic encephalitis (GAE)

Clinical course: Subacute/chronic—weeks to months

Important clue: Cutaneous lesions may precede neurologic disease

Diagnosis: Tissue examination, immunofluorescence, molecular testing such as PCR, and supportive CSF evaluation

Historical problem: Many cases diagnosed postmortem

Treatment: No single reliably effective standardized therapy; multidrug regimens have produced rare survivors

Prognosis: Very poor

⸻

Key clinical pearl: Think of Balamuthia mandrillaris when progressive granulomatous encephalitis develops over weeks to months, particularly when preceded by an unexplained chronic skin lesion. Unlike Naegleria fowleri, which causes rapidly fulminant primary amebic meningoencephalitis after warm-freshwater nasal exposure, Balamuthia typically produces a slower granulomatous CNS disease.

Infectious Disease and Microbiology – Leclercia adecarboxylata

Overview

Leclercia adecarboxylata is a Gram-negative bacillus belonging to the Enterobacterales. It is widely distributed in the environment but is a rare cause of human infection.

When clinically significant infection occurs, it is often opportunistic and may present as bacteremia, respiratory tract infection, or part of a polymicrobial soft-tissue or abscess infection.

Classification

Genus: Leclercia

Species: Leclercia adecarboxylata

Group: Enterobacterales

Historically, this organism has sometimes been confused with Escherichia coli because of similarities in biochemical characteristics.

Microbiologic Characteristics

L. adecarboxylata is:

• Gram-negative bacillus

• Facultatively anaerobic, although older sources may describe it as aerobic

• Motile

• A member of Enterobacterales

• Generally considered an opportunistic organism

Accurate identification may require modern biochemical or molecular laboratory methods because it can resemble other enteric Gram-negative bacilli.

Incubation Period

The incubation period is:

Unknown

There is no characteristic incubation period because infections can arise from several different routes and clinical circumstances.

Epidemiology

L. adecarboxylata has a:

Worldwide distribution

but is a:

Rare cause of human infection

The organism has been recovered from environmental sources such as:

• Water

• Soil

• Other environmental material

Opportunistic Infection

Clinically important disease has particularly been described in patients with:

• Immunosuppression

• Serious underlying disease

• Invasive medical devices

• Disrupted skin or mucosal barriers

• Traumatic wounds

However, infection can occasionally occur in immunocompetent individuals as well.

Bacteremia

L. adecarboxylata can cause:

Bacteremia

Bloodstream infection may occur as an isolated infection or secondary to another infectious focus.

Possible manifestations include:

• Fever

• Chills

• Systemic inflammatory response

• Sepsis in severe cases

Catheter-Associated Infection

Because opportunistic Gram-negative organisms can colonize or infect intravascular devices, L. adecarboxylata has also been reported in association with:

Catheter-related bloodstream infection

When a device-associated infection is suspected, appropriate source control may be necessary in addition to antimicrobial therapy.

Respiratory Tract Infection

The source identifies:

Respiratory tract infections

as another clinical manifestation.

These infections are uncommon and are more clinically significant when the organism is isolated from an appropriate lower respiratory specimen in a patient with compatible signs of infection.

Polymicrobial Infection

An important characteristic is that L. adecarboxylata may occur as part of:

Polymicrobial infections

rather than as the only pathogen.

Examples include:

• Abscesses

• Wound infections

• Soft-tissue infections

Therefore, treatment may need to cover other organisms isolated from the same infectious focus.

Wound and Soft-Tissue Infection

Environmental exposure combined with disruption of the skin barrier can permit L. adecarboxylata to enter tissues.

A useful clinical pattern is:

Traumatic wound

• ●

Environmental contamination

• ●

Gram-negative bacillus isolated from wound/abscess

→ Consider Leclercia adecarboxylata among the uncommon environmental pathogens.

Diagnosis

The principal diagnostic method is:

Culture

Depending on the clinical syndrome, specimens may include:

• Blood

• Respiratory secretions

• Wound cultures

• Abscess material

• Tissue specimens

Laboratory Identification

Because L. adecarboxylata can resemble other Enterobacterales, particularly E. coli, accurate species-level identification may occasionally be challenging.

Modern methods such as:

MALDI-TOF mass spectrometry

can facilitate reliable identification.

Treatment

The source lists:

Fluoroquinolones

as a treatment option.

Additional Treatment

The source also lists:

• Trimethoprim-sulfamethoxazole (TMP-SMX)

• Beta-lactam/beta-lactamase inhibitor combinations

These may be effective depending on the susceptibility of the isolate.

Antimicrobial Susceptibility

Many reported L. adecarboxylata isolates have been susceptible to multiple antimicrobial classes.

However, resistance can occur, including isolates with clinically important beta-lactam resistance mechanisms.

Therefore, treatment of invasive disease should be guided by:

Culture and antimicrobial susceptibility testing

rather than assuming universal susceptibility.

Treatment Principle

For significant L. adecarboxylata infection:

Confirm clinical significance

↓

Determine whether infection is monomicrobial or polymicrobial

↓

Perform susceptibility testing

↓

Choose an active antimicrobial

↓

Provide source control when an abscess or infected device is present

This is particularly important because many reported infections involve wounds, abscesses, or medical devices.

Colonization vs. True Infection

Because L. adecarboxylata is an uncommon organism and can occur in polymicrobial specimens, its clinical significance should be interpreted carefully.

Evidence supporting true infection includes:

• Isolation from a normally sterile site

• Repeated positive cultures

• Compatible clinical manifestations

• Isolation from a deep wound or abscess

• Clinical response to targeted treatment

Leclercia vs. Escherichia coli

Leclercia adecarboxylata

→ Rare opportunistic pathogen

→ Environmental distribution

→ Bacteremia, respiratory and wound infections

→ Frequently encountered in polymicrobial infection

→ Can resemble E. coli in the laboratory

Escherichia coli

→ Common human intestinal flora

→ Very common human pathogen

→ UTI, bacteremia, intra-abdominal infection, and diarrheal disease

→ Much more frequently encountered clinically

High-Yield Clinical Pattern

Rare Gram-negative bacillus

• ●

Immunocompromised patient or disrupted tissue barrier

• ●

Bacteremia, respiratory infection, wound infection, or abscess

• ●

Possible polymicrobial infection

→ Think Leclercia adecarboxylata

Exam Essentials

Organism: Leclercia adecarboxylata

Morphology: Gram-negative bacillus

Group: Enterobacterales

Distribution: Worldwide

Frequency: Rare human pathogen

Environmental association: Soil and water

Incubation: Unknown

Major infection: Bacteremia

Other infections: Respiratory tract, wound, and soft-tissue infections

Important pattern: May occur in polymicrobial abscesses

Important hosts: Often opportunistic, especially with impaired host defenses or disrupted barriers

Diagnosis: Culture

Laboratory issue: May be confused with E. coli

Source treatment: Fluoroquinolone

Additional source treatments: TMP-SMX and beta-lactam/beta-lactamase inhibitor combinations

Management principle: Susceptibility-guided therapy and appropriate source control

Key clinical pearl: Leclercia adecarboxylata is a rare environmental Gram-negative bacillus that should be considered a potential opportunistic pathogen when recovered from blood, deep wounds, or abscesses. It is particularly notable for appearing in polymicrobial infections and for its laboratory resemblance to Escherichia coli.

Infectious Disease and Microbiology – Lassa Virus

Overview

Lassa virus is an enveloped RNA virus in the family Arenaviridae that causes Lassa fever, a viral hemorrhagic fever endemic in West Africa.

Humans usually acquire infection through exposure to urine or feces from the multimammate rat, Mastomys natalensis, although person-to-person transmission can also occur through contact with infected body fluids.

Classification

Virus: Lassa virus

Family: Arenaviridae

Genus: Mammarenavirus

Disease: Lassa fever

The source groups it under the arenaviruses.

Microbiologic Characteristics

Lassa virus is:

• Enveloped

• An RNA virus

• Characterized by two single-stranded RNA genome segments

• Helical in nucleocapsid organization

• An arenavirus

The genome segments are conventionally called:

L segment

and

S segment

Genome Organization

The viral genome is:

Segmented single-stranded RNA

with two major segments.

Arenaviruses have an ambisense coding strategy, meaning that portions of the genome encode proteins in opposite orientations.

Epidemiology

Lassa fever occurs primarily in:

West Africa

Countries with recognized endemic transmission include several areas of the region where the rodent reservoir is common.

Reservoir

The major reservoir is:

Mastomys natalensis

commonly called the:

Multimammate rat

These rodents can carry and shed the virus without necessarily becoming severely ill.

Transmission

Human infection commonly occurs after exposure to:

Rodent urine or feces

Transmission may occur through:

• Contaminated food

• Contaminated household surfaces

• Inhalation of aerosolized contaminated particles

• Direct contact with rodent excreta

Person-to-Person Transmission

Lassa virus can also spread between humans through:

Direct contact with infected blood or body fluids

This is particularly important in:

• Household settings

• Healthcare environments

• Situations with inadequate infection-control precautions

Incubation Period

The typical incubation period is approximately:

6–21 days

Symptoms may initially be nonspecific, which can make early recognition difficult.

Lassa Fever

Clinical Manifestations

Lassa fever may range from mild illness to severe systemic disease.

Early manifestations may include:

• Fever

• Weakness

• Malaise

• Headache

• Myalgia

• Sore throat

Severe Disease

More severe infection can produce:

• Vomiting

• Diarrhea

• Abdominal or chest pain

• Facial swelling

• Hypotension

• Bleeding manifestations

• Shock

• Multiorgan dysfunction

Although classified as a viral hemorrhagic fever, major bleeding is not present in every case.

Hearing Loss

A particularly important complication of Lassa fever is:

Sensorineural hearing loss

Hearing impairment may develop during or after the acute illness and can persist after recovery.

This is one of the most characteristic complications associated with Lassa fever.

Pregnancy

Lassa fever can be especially severe during:

Pregnancy

Maternal and fetal outcomes may be poor, particularly with severe infection.

High-Yield Clinical Pattern

West Africa

• ●

Rodent exposure

• ●

Acute febrile systemic illness

• ●

Possible hemorrhagic manifestations

• ●

Sensorineural hearing loss

→ Think Lassa fever

Diagnosis

The source lists:

• Cell culture

• Serology

Modern diagnosis may also include molecular detection such as:

RT-PCR

especially during acute illness.

Serology

Serologic testing can detect:

Lassa virus-specific antibodies

and may help establish the diagnosis depending on the stage of infection.

Viral Culture

Virus isolation is possible but requires:

High-containment laboratory facilities

because of the infectious risk.

It is therefore not a routine diagnostic method in most clinical laboratories.

Treatment

The source lists:

Ribavirin

Ribavirin has historically been used for severe Lassa fever, particularly when administered early in the course of illness.

Supportive Care

Management also depends heavily on:

• Fluid and electrolyte management

• Hemodynamic support

• Oxygenation and respiratory support when necessary

• Management of bleeding

• Treatment of secondary complications

Supportive care is essential even when antiviral therapy is considered.

Prevention

The source recommends:

Strict isolation for the duration of illness

Modern infection prevention focuses on appropriate isolation and meticulous precautions against exposure to:

Blood and body fluids

Infection-Control Measures

Important measures include:

• Appropriate personal protective equipment

• Safe handling of blood and body fluids

• Safe injection practices

• Proper disposal of contaminated materials

• Appropriate laboratory precautions

• Avoiding unprotected contact with infected patients

Rodent Control

Prevention also requires limiting exposure to the reservoir.

Useful measures include:

• Keeping food in rodent-proof containers

• Maintaining clean household environments

• Reducing rodent access to homes

• Avoiding consumption of food contaminated with rodent excreta

• Safe handling of rodents

Lassa Virus vs. Ebola Virus

Lassa virus

→ Arenavirus

→ Rodent reservoir

→ West Africa

→ Ribavirin historically used

→ Hearing loss is a characteristic complication

Ebola virus

→ Filovirus

→ Primarily spread through infected body fluids during outbreaks

→ Severe hemorrhagic/systemic illness

→ Specific monoclonal antibody therapies are available for some Ebola virus disease

High-Yield Reservoir Pattern

Mastomys natalensis

• ●

Rodent urine/feces exposure

• ●

West Africa

→ Lassa virus

Exam Essentials

Virus: Lassa virus

Family: Arenaviridae

Genus: Mammarenavirus

Genome: Two segmented single-stranded RNA segments

Envelope: Present

Nucleocapsid symmetry: Helical

Geography: West Africa

Reservoir: Mastomys natalensis

Transmission: Rodent excreta; infected human blood/body fluids

Disease: Lassa fever

Incubation: Approximately 6–21 days

Major complication: Sensorineural hearing loss

Diagnosis: Serology, RT-PCR; culture in specialized laboratories

Treatment in source: Ribavirin

Supportive care: Essential

Prevention: Rodent control and strict blood/body-fluid infection precautions

Key clinical pearl: Think of Lassa fever in a patient from or exposed in West Africa who develops an acute febrile illness after rodent exposure, particularly when sensorineural hearing loss occurs. The classic reservoir is the multimammate rat, Mastomys natalensis.

Infectious Disease and Microbiology – Lactobacillus Species

Overview

Lactobacillus species are Gram-positive, microaerophilic bacilli that normally colonize several areas of the human body, particularly the vagina, oral cavity, and gastrointestinal tract. They are also commonly present in fermented foods and some probiotic preparations.

Although Lactobacillus organisms are usually beneficial commensals with low pathogenic potential, they can occasionally cause serious opportunistic infections such as bacteremia and endocarditis, particularly when host defenses or normal anatomic barriers are disrupted.

Important Species

The source lists:

• Lactobacillus acidophilus

• Lactobacillus casei

• Lactobacillus plantarum

• Lactobacillus rhamnosus

• Lactobacillus salivarius

• Other Lactobacillus species

Taxonomy within this group has undergone substantial revision, so several organisms historically classified as Lactobacillus have subsequently been reassigned to other genera.

Microbiologic Characteristics

Lactobacillus species are generally:

• Gram-positive bacilli

• Non-spore-forming

• Microaerophilic or aerotolerant

• Catalase-negative

• Lactic acid-producing organisms

Their ability to produce lactic acid is especially important in maintaining the normal vaginal environment.

Normal Human Flora

Lactobacillus species commonly colonize the:

Vagina

Oral cavity

Gastrointestinal tract

Therefore, recovery of Lactobacillus from a nonsterile specimen does not necessarily indicate infection.

Vaginal Microbiology

Protective Role of Lactobacilli

In the healthy reproductive-age vagina, lactobacilli contribute to a:

Low vaginal pH

through production of lactic acid.

This acidic environment helps inhibit the proliferation of many potentially pathogenic organisms.

Thus:

Abundant vaginal lactobacilli

→ Lactic acid production

→ Low vaginal pH

→ Suppression of competing organisms

Hormonal Influence

The vaginal Lactobacillus population is influenced by the hormonal environment.

Changes in hormone levels can alter:

• Vaginal epithelial characteristics

• Glycogen availability

• Lactobacillus abundance

• Vaginal pH

• Colonization by other microorganisms

Loss or reduction of protective lactobacilli may permit overgrowth of other bacterial species.

Clinical Significance

A reduction in vaginal lactobacilli can disturb the normal vaginal microbial ecosystem.

This concept is especially important in understanding:

Bacterial vaginosis

in which normal lactobacillus-dominant flora is replaced by a polymicrobial community containing anaerobic and other organisms.

Alterations in vaginal flora may also influence susceptibility to some urinary and genital infections.

Food and Probiotic Association

Lactobacillus species are also found in various:

• Fermented foods

• Dairy products

• Probiotic preparations

Most exposure does not cause disease.

However, in unusual circumstances—particularly in highly vulnerable patients—organisms traditionally regarded as low-virulence commensals can become opportunistic pathogens.

Incubation Period

A conventional incubation period is generally not applicable because most clinically significant infections are:

Endogenous

Infection can develop when organisms belonging to the patient’s normal flora gain access to normally sterile tissues or the bloodstream.

Epidemiology

Lactobacillus species are:

Widely distributed

and commonly present as part of normal human flora.

Invasive infections are relatively uncommon compared with the frequency of colonization.

Bacteremia

Lactobacillus Bacteremia

Lactobacillus species can occasionally cause:

Bacteremia

The source particularly emphasizes bacteremia in:

Neutropenic patients

Other severely immunocompromised or critically ill patients may also be vulnerable to invasive infection.

Interpreting Positive Blood Cultures

Because Lactobacillus is normally associated with human flora, its recovery from blood requires clinical interpretation.

A positive culture should not automatically be dismissed when there are:

• Multiple positive blood cultures

• Persistent fever or sepsis

• Immunosuppression

• Neutropenia

• Evidence of endocarditis

• Another compatible invasive focus

Endocarditis

Lactobacillus species are rare but recognized causes of:

Infective endocarditis

This is one of the most important serious infections associated with the genus.

Clinical Features

Possible manifestations include:

• Persistent fever

• Bacteremia

• New or changing cardiac murmur

• Valvular vegetation

• Embolic complications

• Other manifestations of infective endocarditis

Persistent Lactobacillus bacteremia should therefore raise concern for an endovascular source.

High-Yield Endocarditis Pattern

Persistent Lactobacillus bacteremia

• ●

Compatible cardiac findings

• ●

Valvular vegetation

→ Consider Lactobacillus endocarditis

Do not automatically interpret the organism as insignificant normal flora.

Neonatal Meningitis

The source identifies:

Neonatal meningitis

as a rare invasive manifestation.

Neonates are particularly susceptible to invasive infections because of their relatively immature immune defenses.

Amnionitis

Lactobacillus species have occasionally been associated with:

Amnionitis

or infection involving the amniotic membranes and intrauterine environment.

This represents an uncommon complication because lactobacilli are normally associated with the lower female genital tract rather than invasive disease.

Mediastinitis

Another rare invasive manifestation listed in the source is:

Mediastinitis

This illustrates the ability of normally low-virulence organisms to cause severe disease when introduced into normally sterile tissues.

Diagnosis

The principal diagnostic method is:

Culture

Appropriate specimens depend on the suspected infection and may include:

• Blood cultures

• Cerebrospinal fluid

• Tissue specimens

• Amniotic specimens

• Material obtained from other normally sterile sites

Colonization vs. True Infection

An important clinical principle is distinguishing:

Normal flora/colonization

from:

True invasive infection

Isolation from the vagina, mouth, or gastrointestinal tract is usually compatible with normal colonization.

In contrast:

Repeated isolation from blood or another normally sterile site + compatible clinical disease

provides much stronger evidence of infection.

Treatment

The source lists:

Penicillin G

as the primary treatment.

Additional Treatment

The source lists:

Amoxicillin

as an additional option.

However, clinically important Lactobacillus infections are uncommon, and antimicrobial susceptibility varies among species.

Therefore, serious invasive disease should ideally be managed according to:

Species identification + antimicrobial susceptibility testing + infection site

Important Antimicrobial Consideration

Not all Lactobacillus species have identical antimicrobial susceptibility patterns.

A particularly useful clinical point is that vancomycin cannot be assumed to provide reliable activity against all lactobacilli; some species have intrinsic or substantial resistance.

Thus, treatment of serious infection should not rely solely on the assumption that every Gram-positive organism will respond to vancomycin.

Treatment Principle

For suspected invasive Lactobacillus infection:

Confirm that the isolate represents true infection

↓

Identify the species when possible

↓

Perform susceptibility testing

↓

Look for a source, especially endocarditis in persistent bacteremia

↓

Use an active antimicrobial

The source emphasizes penicillin G or amoxicillin, but definitive therapy should be individualized according to susceptibility and clinical syndrome.

Lactobacillus and Bacterial Vaginosis

A useful microbiologic contrast is:

Normal vaginal flora

→ Lactobacillus-dominant

→ Lactic acid production

→ Low vaginal pH

Bacterial vaginosis

→ Decreased protective lactobacilli

→ Increased polymicrobial anaerobic flora

→ Increased vaginal pH

→ Clue cells may be present

Thus, in the vagina, Lactobacillus is generally protective rather than pathogenic.

High-Yield Clinical Pattern

Gram-positive bacillus

• ●

Normal vaginal/oral/GI flora

• ●

Lactic acid production

• ●

Usually nonpathogenic

• ●

Rare bacteremia or endocarditis in susceptible patients

→ Think Lactobacillus

Exam Essentials

Genus: Lactobacillus

Important species in source: L. acidophilus, L. casei, L. plantarum, L. rhamnosus, L. salivarius

Morphology: Gram-positive bacillus

Oxygen relationship: Microaerophilic/aerotolerant

Major metabolic product: Lactic acid

Normal flora: Vagina, oral cavity, gastrointestinal tract

Food association: Fermented foods and some probiotics

Vaginal function: Helps maintain low vaginal pH

Incubation: Usually not applicable; infection is commonly endogenous

Major invasive infections: Endocarditis and bacteremia

Important bacteremia risk in source: Neutropenia

Other infections: Neonatal meningitis, amnionitis, mediastinitis

Diagnosis: Culture

Source treatment: Penicillin G

Additional source treatment: Amoxicillin

Important treatment principle: Susceptibility varies by species

Vancomycin: Not reliably active against all Lactobacillus species

Key clinical pearl: Lactobacillus species are normally protective Gram-positive members of the vaginal, oral, and gastrointestinal flora, but they can rarely become invasive pathogens. Persistent Lactobacillus bacteremia—especially in a vulnerable patient—should not automatically be dismissed as contamination and should prompt evaluation for a true focus such as infective endocarditis.

Important Species The source lists: • Lactobacillus acidophilus

• Lactobacillus casei

• Lactobacillus plantarum

• Lactobacillus rhamnosus

• Lactobacillus salivarius

• Other Lactobacillus species Taxonomy within this group has undergone substantial revision, so several organisms historically classified as Lactobacillus have subsequently been reassigned to other genera. 

Microbiologic Characteristics Lactobacillus species are generally: • Gram-positive bacilli

• Non-spore-forming

• Microaerophilic or aerotolerant

• Catalase-negative

• Lactic acid-producing organisms Their ability to produce lactic acid is especially important in maintaining the normal vaginal environment. 

Normal Human Flora Lactobacillus species commonly colonize the: Vagina Oral cavity Gastrointestinal tract Therefore, recovery of Lactobacillus from a nonsterile specimen does not necessarily indicate infection. 

Vaginal Microbiology Protective Role of Lactobacilli In the healthy reproductive-age vagina, lactobacilli contribute to a: Low vaginal pH through production of lactic acid. This acidic environment helps inhibit the proliferation of many potentially pathogenic organisms. Thus: Abundant vaginal lactobacilli → Lactic acid production → Low vaginal pH → Suppression of competing organisms 

Hormonal Influence The vaginal Lactobacillus population is influenced by the hormonal environment. Changes in hormone levels can alter: • Vaginal epithelial characteristics

• Glycogen availability

• Lactobacillus abundance

• Vaginal pH

• Colonization by other microorganisms Loss or reduction of protective lactobacilli may permit overgrowth of other bacterial species. 

Clinical Significance A reduction in vaginal lactobacilli can disturb the normal vaginal microbial ecosystem. This concept is especially important in understanding: Bacterial vaginosis in which normal lactobacillus-dominant flora is replaced by a polymicrobial community containing anaerobic and other organisms. Alterations in vaginal flora may also influence susceptibility to some urinary and genital infections. 

Food and Probiotic Association Lactobacillus species are also found in various: • Fermented foods

• Dairy products

• Probiotic preparations Most exposure does not cause disease. However, in unusual circumstances—particularly in highly vulnerable patients—organisms traditionally regarded as low-virulence commensals can become opportunistic pathogens. 

Incubation Period A conventional incubation period is generally not applicable because most clinically significant infections are: Endogenous Infection can develop when organisms belonging to the patient’s normal flora gain access to normally sterile tissues or the bloodstream. 

Epidemiology Lactobacillus species are: Widely distributed and commonly present as part of normal human flora. Invasive infections are relatively uncommon compared with the frequency of colonization. 

Bacteremia Lactobacillus Bacteremia Lactobacillus species can occasionally cause: Bacteremia The source particularly emphasizes bacteremia in: Neutropenic patients Other severely immunocompromised or critically ill patients may also be vulnerable to invasive infection. 

Interpreting Positive Blood Cultures Because Lactobacillus is normally associated with human flora, its recovery from blood requires clinical interpretation. A positive culture should not automatically be dismissed when there are: • Multiple positive blood cultures

• Persistent fever or sepsis

• Immunosuppression

• Neutropenia

• Evidence of endocarditis

• Another compatible invasive focus 

Endocarditis Lactobacillus species are rare but recognized causes of: Infective endocarditis This is one of the most important serious infections associated with the genus. 

Clinical Features Possible manifestations include: • Persistent fever

• Bacteremia

• New or changing cardiac murmur

• Valvular vegetation

• Embolic complications

• Other manifestations of infective endocarditis Persistent Lactobacillus bacteremia should therefore raise concern for an endovascular source. 

High-Yield Endocarditis Pattern Persistent Lactobacillus bacteremia  ●  Compatible cardiac findings  ●  Valvular vegetation → Consider Lactobacillus endocarditis Do not automatically interpret the organism as insignificant normal flora. 

Neonatal Meningitis The source identifies: Neonatal meningitis as a rare invasive manifestation. Neonates are particularly susceptible to invasive infections because of their relatively immature immune defenses. 

Amnionitis Lactobacillus species have occasionally been associated with: Amnionitis or infection involving the amniotic membranes and intrauterine environment. This represents an uncommon complication because lactobacilli are normally associated with the lower female genital tract rather than invasive disease. 

Mediastinitis Another rare invasive manifestation listed in the source is: Mediastinitis This illustrates the ability of normally low-virulence organisms to cause severe disease when introduced into normally sterile tissues. 

Diagnosis The principal diagnostic method is: Culture Appropriate specimens depend on the suspected infection and may include: • Blood cultures

• Cerebrospinal fluid

• Tissue specimens

• Amniotic specimens

• Material obtained from other normally sterile sites 

Colonization vs. True Infection An important clinical principle is distinguishing: Normal flora/colonization from: True invasive infection Isolation from the vagina, mouth, or gastrointestinal tract is usually compatible with normal colonization. In contrast: Repeated isolation from blood or another normally sterile site + compatible clinical disease provides much stronger evidence of infection. 

Treatment The source lists: Penicillin G as the primary treatment. 

Additional Treatment The source lists: Amoxicillin as an additional option. However, clinically important Lactobacillus infections are uncommon, and antimicrobial susceptibility varies among species. Therefore, serious invasive disease should ideally be managed according to: Species identification + antimicrobial susceptibility testing + infection site 

Important Antimicrobial Consideration Not all Lactobacillus species have identical antimicrobial susceptibility patterns. A particularly useful clinical point is that vancomycin cannot be assumed to provide reliable activity against all lactobacilli; some species have intrinsic or substantial resistance. Thus, treatment of serious infection should not rely solely on the assumption that every Gram-positive organism will respond to vancomycin. 

Treatment Principle For suspected invasive Lactobacillus infection: Confirm that the isolate represents true infection ↓ Identify the species when possible ↓ Perform susceptibility testing ↓ Look for a source, especially endocarditis in persistent bacteremia ↓ Use an active antimicrobial The source emphasizes penicillin G or amoxicillin, but definitive therapy should be individualized according to susceptibility and clinical syndrome. 

Lactobacillus and Bacterial Vaginosis A useful microbiologic contrast is: Normal vaginal flora → Lactobacillus-dominant

→ Lactic acid production

→ Low vaginal pH Bacterial vaginosis → Decreased protective lactobacilli

→ Increased polymicrobial anaerobic flora

→ Increased vaginal pH

→ Clue cells may be present Thus, in the vagina, Lactobacillus is generally protective rather than pathogenic. 

High-Yield Clinical Pattern Gram-positive bacillus  ●  Normal vaginal/oral/GI flora  ●  Lactic acid production  ●  Usually nonpathogenic  ●  Rare bacteremia or endocarditis in susceptible patients → Think Lactobacillus 

Exam Essentials Genus: Lactobacillus

Important species in source: L. acidophilus, L. casei, L. plantarum, L. rhamnosus, L. salivarius

Morphology: Gram-positive bacillus

Oxygen relationship: Microaerophilic/aerotolerant

Major metabolic product: Lactic acid

Normal flora: Vagina, oral cavity, gastrointestinal tract

Food association: Fermented foods and some probiotics

Vaginal function: Helps maintain low vaginal pH

Incubation: Usually not applicable; infection is commonly endogenous

Major invasive infections: Endocarditis and bacteremia

Important bacteremia risk in source: Neutropenia

Other infections: Neonatal meningitis, amnionitis, mediastinitis

Diagnosis: Culture

Source treatment: Penicillin G

Additional source treatment: Amoxicillin

Important treatment principle: Susceptibility varies by species

Vancomycin: Not reliably active against all Lactobacillus species 

Key clinical pearl: Lactobacillus species are normally protective Gram-positive members of the vaginal, oral, and gastrointestinal flora, but they can rarely become invasive pathogens. Persistent Lactobacillus bacteremia—especially in a vulnerable patient—should not automatically be dismissed as contamination and should prompt evaluation for a true focus such as infective endocarditis.

Infectious Disease and Microbiology – Kyasanur Forest Disease Virus

Overview

Kyasanur Forest disease virus (KFDV) is an enveloped, positive-sense single-stranded RNA virus belonging to the genus Flavivirus. It causes Kyasanur Forest disease (KFD), an acute tick-borne viral hemorrhagic fever characterized by high fever, severe constitutional symptoms, and sometimes hemorrhagic manifestations.

The disease is classically associated with India, particularly forested areas of southern and southwestern India, and is sometimes called monkey fever because outbreaks in monkeys can signal viral activity in an area.

⸻

Important Correction

The source lists the major infection as:

“Hemorrhagic fever with renal syndrome.”

This is not the classic syndrome caused by Kyasanur Forest disease virus.

Hemorrhagic fever with renal syndrome (HFRS) is classically caused by hantaviruses.

KFDV instead causes:

Kyasanur Forest disease → acute febrile illness with possible hemorrhagic manifestations

Renal involvement is not the defining feature of KFD.

⸻

Classification

Virus: Kyasanur Forest disease virus

Abbreviation: KFDV

Genus: Flavivirus

Family: Flaviviridae

Disease: Kyasanur Forest disease (KFD)

It is an arthropod-borne virus (arbovirus) transmitted primarily through ticks.

⸻

Microbiologic Characteristics

KFDV is:

• Positive-sense single-stranded RNA virus

• Enveloped

• Approximately spherical in viral morphology

• A member of the Flavivirus genus

• An arbovirus

Its basic structure is similar to that of other medically important flaviviruses.

⸻

Incubation Period

The incubation period is approximately:

3–8 days

Symptoms generally begin abruptly after this incubation period.

⸻

Epidemiology

KFD was first recognized in Karnataka, India, in the Kyasanur Forest region.

The disease has subsequently been identified in additional areas of India.

The source also mentions China, Southeast Asia, and Saudi Arabia; however, the strongest classic epidemiologic association for KFD itself is:

Forested regions of India

Related tick-borne flaviviruses occur elsewhere in Asia and the Middle East.

⸻

Reservoirs and Ecology

KFDV circulates in an ecological cycle involving:

Ticks + small mammals + other vertebrate hosts

Monkeys can develop severe disease and die during outbreaks, making monkey deaths an important epidemiologic warning signal.

However, monkeys are not simply the permanent reservoir of the virus.

⸻

Vector

The principal vectors are:

Haemaphysalis ticks

Humans generally become infected after entering forest environments where infected ticks are present.

⸻

Transmission

The major route of human infection is:

Bite of an infected tick

People at increased exposure risk may include:

• Forest workers

• Farmers

• Hunters

• People collecting forest products

• Residents of affected forested regions

Routine person-to-person transmission is not considered a characteristic feature.

⸻

Kyasanur Forest Disease

Initial Febrile Phase

Disease usually begins abruptly with:

• High fever

• Severe headache

• Myalgia

• Generalized weakness

• Chills

• Gastrointestinal symptoms

Patients may become significantly ill during the initial febrile period.

⸻

Hemorrhagic Manifestations

Some patients develop:

Hemorrhagic features

which may include:

• Petechiae

• Epistaxis

• Gastrointestinal bleeding

• Other mucosal bleeding manifestations

Thrombocytopenia and other hematologic abnormalities may accompany severe disease.

⸻

Biphasic Disease

An important feature is that some patients experience a:

Biphasic illness

After apparent improvement from the initial febrile illness, fever can recur.

⸻

Neurologic Manifestations

During a second phase, some patients may develop neurologic manifestations such as:

• Severe headache

• Tremor

• Altered mental status

• Meningoencephalitic features

Thus, KFD can occasionally involve the central nervous system.

⸻

High-Yield Clinical Pattern

Forested region of India

Tick exposure

Abrupt high fever and severe myalgia

Possible hemorrhagic manifestations

→ Think Kyasanur Forest disease virus

⸻

Monkey Fever Association

A memorable epidemiologic clue is:

Monkey deaths in an endemic forest

Human tick exposure

Acute febrile hemorrhagic illness

→ Consider Kyasanur Forest disease

This explains the commonly used term:

“Monkey fever”

⸻

Diagnosis

The source lists:

• Cell culture

• Serology

• PCR

⸻

PCR

Molecular detection using:

RT-PCR

is particularly useful during the acute viremic phase.

It can detect viral RNA in appropriate clinical specimens.

⸻

Serology

Serologic testing can identify virus-specific antibodies and becomes particularly useful as the immune response develops.

Thus, diagnostic testing may depend on the stage of illness.

⸻

Viral Culture

The virus can be isolated in specialized laboratory settings, but routine clinical diagnosis generally relies more heavily on:

Molecular testing and serology

because handling live virus requires appropriate biosafety precautions.

⸻

Treatment

The source correctly emphasizes:

Symptomatic/supportive treatment

There is no established routine specific antiviral therapy that reliably eliminates KFDV infection.

⸻

Supportive Management

Management may include:

• Adequate hydration

• Hemodynamic monitoring

• Management of bleeding

• Correction of electrolyte abnormalities

• Respiratory support when necessary

• Management of neurologic complications

Patients with severe hemorrhage or hemodynamic instability require close monitoring.

⸻

Prevention

Because KFD is predominantly tick-borne, prevention focuses on reducing tick exposure.

Important measures include:

• Protective clothing in endemic forests

• Appropriate tick repellents

• Checking the body for ticks after forest exposure

• Environmental/vector-control measures where appropriate

• Public-health surveillance during outbreaks

⸻

KFD vs. Hantavirus HFRS

Kyasanur Forest disease virus

→ Flavivirus

→ Positive-sense ssRNA

→ Tick-borne

→ India

→ Acute febrile/hemorrhagic illness

→ May have a biphasic course

Hantavirus causing HFRS

→ Hantavirus

→ Negative-sense segmented ssRNA

→ Primarily rodent-associated transmission

→ Hemorrhagic fever with renal syndrome

→ Acute kidney injury is a defining manifestation

This distinction corrects the major syndrome error in the source.

⸻

Comparison With Other Flaviviruses

Kyasanur Forest disease virus

→ Tick-borne

→ Hemorrhagic febrile illness

→ India

Japanese encephalitis virus

→ Mosquito-borne

→ Encephalitis

→ Asia

Dengue virus

→ Aedes mosquito-borne

→ Fever, thrombocytopenia, vascular leakage/hemorrhagic manifestations

Yellow fever virus

→ Mosquito-borne

→ Fever, hepatitis, jaundice, hemorrhage

⸻

Exam Essentials

Virus: Kyasanur Forest disease virus (KFDV)

Genus: Flavivirus

Family: Flaviviridae

Genome: Positive-sense single-stranded RNA

Envelope: Present

Morphology: Approximately spherical

Incubation: 3–8 days

Classic geography: India

Transmission: Tick bite

Major vector: Haemaphysalis ticks

Common name: Monkey fever

Major syndrome: Acute febrile illness with possible hemorrhagic manifestations

Possible course: Biphasic

Possible complication: Neurologic disease during a second phase

Diagnosis: RT-PCR and serology

Treatment: Supportive

Prevention: Avoid/reduce tick exposure

Important correction: HFRS is classically a hantavirus syndrome, not the defining disease caused by KFDV

⸻

Key clinical pearl: Kyasanur Forest disease virus is a tick-borne flavivirus classically associated with forested regions of India. Think of KFD when forest/tick exposure is followed by abrupt high fever, severe myalgia, and possible hemorrhagic manifestations; do not confuse it with hantavirus-associated hemorrhagic fever with renal syndrome.

Infectious Disease and Microbiology – Kurthia Species

Overview

Kurthia species are aerobic Gram-positive bacilli that are widely distributed in the environment but only rarely cause human infection. Reported invasive manifestations include bacteremia and infective endocarditis.

The source particularly notes an association between infections caused by unusual aerobic Gram-positive bacilli, including Kurthia, and intravenous drug use.

Important Species

The source lists:

• Kurthia gibsonii

• Kurthia sibirica

• Kurthia zopfii

Human infections caused by these organisms are uncommon, so clinical experience and treatment data are limited.

Microbiologic Characteristics

Kurthia species are:

• Gram-positive bacilli

• Aerobic

• Generally non-spore-forming

• Environmental organisms

• Rare opportunistic human pathogens

When an unusual Gram-positive bacillus is isolated from a clinical specimen, its significance should be interpreted according to the specimen source and clinical circumstances.

Incubation Period

The incubation period is:

Unknown

A clearly defined incubation period is generally not applicable because Kurthia infections are rare and may follow environmental exposure or entry through disrupted skin or other barriers.

Epidemiology

Kurthia species have a:

Worldwide distribution

Despite their broad environmental distribution, clinically significant human infections are:

Rare

Environmental Distribution

Kurthia species have been recovered from environmental sources and may occasionally be encountered as organisms of uncertain clinical significance.

Therefore:

Isolation does not automatically equal infection.

Recovery from a normally sterile site such as blood, particularly in multiple cultures and in a patient with compatible symptoms, provides stronger evidence of true invasive disease.

Intravenous Drug Use

The source identifies:

Intravenous drug use

as a risk factor for infections caused by unusual aerobic Gram-positive bacilli, including Kurthia species.

Injection can provide organisms with direct access to the bloodstream, creating the potential for:

Bacteremia

and subsequent:

Cardiac valve infection → endocarditis

Bacteremia

Kurthia species can rarely cause:

Bacteremia

Clinical manifestations may include:

• Fever

• Chills

• Systemic inflammatory manifestations

• Persistent positive blood cultures

• Sepsis in severe cases

Persistent bacteremia should prompt investigation for a deeper focus of infection.

Endocarditis

Major Invasive Manifestation

An important reported infection is:

Infective endocarditis

This is particularly relevant when Kurthia is repeatedly recovered from blood cultures in a patient with appropriate risk factors.

Clinical Manifestations

Possible findings include:

• Persistent fever

• Cardiac murmur

• Positive blood cultures

• Valvular vegetation on echocardiography

• Embolic phenomena

• Other complications of infective endocarditis

High-Yield Endocarditis Pattern

Intravenous drug use

• ●

Persistent bacteremia

• ●

Unusual aerobic Gram-positive bacillus

• ●

Evidence of valvular infection

→ Consider Kurthia species among the rare possible causes of endocarditis.

Diagnosis

The source lists:

Culture

as the principal diagnostic method.

For suspected invasive disease, the most important specimens are typically:

Blood cultures

Species identification may require careful laboratory characterization because uncommon Gram-positive bacilli can be confused with other organisms.

Contamination vs. True Infection

Because unusual environmental Gram-positive bacilli may occasionally appear in cultures, clinicians must distinguish:

Contamination or transient colonization

from:

True invasive infection

Evidence favoring true infection includes:

• Multiple positive blood cultures

• Compatible systemic illness

• Persistent bacteremia

• Endocarditis findings

• Relevant host risk factors

Treatment

The source recommends:

Penicillin G

For endocarditis, it describes:

Penicillin G + an aminoglycoside

This represents the historical treatment approach provided in the source.

Additional Treatment

The source lists:

• Trimethoprim-sulfamethoxazole

• Chloramphenicol

• Erythromycin

Because human Kurthia infections are extremely uncommon, there are limited clinical data establishing an optimal standardized regimen.

Treatment Principle

For clinically significant Kurthia infection:

Confirm true infection

↓

Identify the organism

↓

Perform antimicrobial susceptibility testing when possible

↓

Determine whether endocarditis or another deep focus is present

↓

Select susceptibility-guided antimicrobial therapy

For endocarditis, prolonged therapy and specialist management may be necessary.

High-Yield Clinical Pattern

Rare Gram-positive bacillus

• ●

Bacteremia

• ●

Intravenous drug use or another bloodstream-access risk

• ●

Possible endocarditis

→ Think of Kurthia as a rare opportunistic pathogen.

Exam Essentials

Genus: Kurthia

Species: K. gibsonii, K. sibirica, K. zopfii

Morphology: Gram-positive bacillus

Oxygen relationship: Aerobic

Distribution: Worldwide

Frequency: Rare human pathogen

Incubation: Unknown

Important risk factor in source: Intravenous drug use

Major infections: Bacteremia and endocarditis

Diagnosis: Culture

Important diagnostic issue: Distinguish contamination from true bloodstream infection

Historical endocarditis treatment: Penicillin G + aminoglycoside

Additional agents in source: TMP-SMX, chloramphenicol, erythromycin

Modern management principle: Species identification and susceptibility-guided therapy

Key clinical pearl: Kurthia species are rare aerobic Gram-positive bacilli that can occasionally cause true bacteremia and endocarditis. When the organism is repeatedly isolated from blood—particularly in a patient with risk factors such as intravenous drug use—it should not automatically be dismissed as a contaminant.

Infectious Disease and Microbiology – Kluyvera Species

Overview

Kluyvera species are Gram-negative bacilli within the Enterobacterales that are uncommon causes of human infection. They have a worldwide distribution and may colonize humans without producing disease.

When infection occurs, it is often opportunistic or endogenous and may present as bacteremia, urinary tract infection, soft-tissue infection, or pneumonia, particularly in immunocompromised patients.

Important Species

The source lists:

• Kluyvera ascorbata

• Kluyvera cryocrescens

The source spelling “K. cryorencens” appears to be an error; the recognized species name is:

Kluyvera cryocrescens

Microbiologic Characteristics

Kluyvera species are:

• Gram-negative bacilli

• Facultatively anaerobic members of Enterobacterales

• Generally motile

• Opportunistic pathogens

• Uncommon causes of clinically significant infection

Older references may describe them simply as aerobic Gram-negative bacilli.

Incubation Period

A specific incubation period is generally not applicable because infection is usually:

Endogenous

Disease may develop when colonizing organisms enter normally sterile sites, particularly in patients with disrupted host defenses.

Epidemiology

Kluyvera species have a:

Worldwide distribution

However, clinically significant infection is:

Rare

Isolation therefore requires interpretation in the context of the patient’s symptoms, specimen source, and underlying risk factors.

Opportunistic Infection

Kluyvera behaves primarily as an opportunistic pathogen.

Infection is more likely in patients with:

• Immunosuppression

• Serious underlying illness

• Prolonged hospitalization

• Invasive devices

• Disruption of normal anatomic barriers

Nevertheless, infections can occasionally occur in otherwise healthy individuals.

Bacteremia

Kluyvera species can cause:

Bacteremia

Bloodstream infection may arise from another focus such as the:

• Urinary tract

• Soft tissues

• Respiratory tract

Severe cases may progress to systemic sepsis.

High-Yield Bacteremia Pattern

Hospitalized or immunocompromised patient

• ●

Unusual Enterobacterales isolated from blood

• ●

Possible urinary or soft-tissue source

→ Consider Kluyvera species

Urinary Tract Infection

Kluyvera species have been associated with:

Urinary tract infections

Clinical presentations may include:

• Cystitis

• Pyelonephritis

• Complicated urinary infection

• Urosepsis

Urine culture with susceptibility testing is important because antimicrobial resistance patterns may vary.

Soft-Tissue Infection

The organisms can occasionally produce:

Skin and soft-tissue infection

Potential manifestations include:

• Wound infection

• Cellulitis

• Abscess formation

Management may require both appropriate antimicrobial therapy and source control, such as drainage or debridement when indicated.

Pneumonia

The source particularly associates Kluyvera with:

Pneumonia in immunosuppressed patients

Respiratory isolation should be interpreted carefully because the clinical significance of an unusual Gram-negative organism depends on the specimen quality and evidence of true lower respiratory tract infection.

Diagnosis

The primary diagnostic method is:

Culture

Depending on the clinical syndrome, specimens may include:

• Blood

• Urine

• Respiratory specimens

• Wound material

• Abscess fluid

• Tissue specimens

Species identification and antimicrobial susceptibility testing are particularly useful because Kluyvera infections are uncommon.

Antimicrobial Resistance

Important Feature

The source emphasizes that information about antimicrobial susceptibility is limited.

Historically, Kluyvera species have demonstrated resistance to:

• Ampicillin

• First-generation cephalosporins

• Second-generation cephalosporins

Therefore, these agents should not automatically be assumed to provide reliable therapy.

Beta-Lactamase Significance

A particularly important microbiologic feature is that some Kluyvera species possess chromosomal beta-lactamases.

Kluyvera ascorbata is especially notable in antimicrobial-resistance microbiology because it has been recognized as a reservoir associated with the evolutionary origin of certain CTX-M-type extended-spectrum beta-lactamases (ESBLs).

This makes Kluyvera important not only as a rare pathogen but also in the study of beta-lactam resistance genes.

Treatment

The source states that several antimicrobial classes are usually active, including:

• Third-generation cephalosporins

• Antipseudomonal agents

• Fluoroquinolones

• Aminoglycosides

However, because susceptibility can vary, treatment should be based whenever possible on:

Culture + susceptibility testing

Additional Treatment

The source also lists:

Chloramphenicol

as an additional treatment option.

This represents an older therapeutic option and is not generally a preferred routine treatment when safer active alternatives are available.

Treatment Principle

Because Kluyvera infections are rare and resistance patterns can vary:

Identify the organism

↓

Perform antimicrobial susceptibility testing

↓

Determine the infection site and severity

↓

Select an active antimicrobial

↓

Provide source control when necessary

This approach is more useful than relying on a single standard regimen.

High-Yield Clinical Pattern

Immunocompromised or hospitalized patient

• ●

Bacteremia, UTI, soft-tissue infection, or pneumonia

• ●

Uncommon Gram-negative bacillus

• ●

Resistance to ampicillin/early-generation cephalosporins

→ Consider Kluyvera species

Resistance High-Yield Pattern

Kluyvera ascorbata

• ●

Chromosomal beta-lactamase

• ●

Evolutionary reservoir associated with CTX-M-type ESBL genes

→ Important connection between Kluyvera and antimicrobial resistance

Kluyvera vs. Klebsiella

Kluyvera

→ Rare opportunistic pathogen

→ Bacteremia, UTI, soft-tissue infection, pneumonia

→ Important beta-lactamase reservoir

→ Susceptibility-guided treatment

Klebsiella

→ Much more common pathogen

→ Pneumonia, UTI, bacteremia

→ Prominent polysaccharide capsule

→ Nonmotile

→ ESBL and carbapenemase resistance are major clinical concerns

Exam Essentials

Genus: Kluyvera

Important species: K. ascorbata, K. cryocrescens

Source correction: “K. cryorencens” → K. cryocrescens

Morphology: Gram-negative bacillus

Group: Enterobacterales

Distribution: Worldwide

Frequency: Rare human pathogen

Source of infection: Frequently endogenous/opportunistic

Major infections: Bacteremia, UTI, soft-tissue infection

Important host: Immunocompromised patients

Respiratory manifestation: Pneumonia

Diagnosis: Culture

Important resistance: Ampicillin and early-generation cephalosporins may be unreliable

Important microbiology association: K. ascorbata and CTX-M-type ESBL ancestry

Potential active agents in source: Third-generation cephalosporins, fluoroquinolones, antipseudomonal agents, aminoglycosides

Historical additional treatment: Chloramphenicol

Management principle: Susceptibility-guided antimicrobial therapy

Key clinical pearl: Kluyvera species are rare opportunistic Gram-negative bacilli that can cause bacteremia, UTI, soft-tissue infection, and pneumonia. K. ascorbata is especially notable because its chromosomal beta-lactamases are linked to the evolutionary origin of important CTX-M-type ESBL resistance determinants.

Important Species The source lists: • Kluyvera ascorbata

• Kluyvera cryocrescens The source spelling “K. cryorencens” appears to be an error; the recognized species name is: Kluyvera cryocrescens

Microbiologic Characteristics Kluyvera species are: • Gram-negative bacilli

• Facultatively anaerobic members of Enterobacterales

• Generally motile

• Opportunistic pathogens

• Uncommon causes of clinically significant infection Older references may describe them simply as aerobic Gram-negative bacilli.

Incubation Period A specific incubation period is generally not applicable because infection is usually: Endogenous Disease may develop when colonizing organisms enter normally sterile sites, particularly in patients with disrupted host defenses.

Epidemiology Kluyvera species have a: Worldwide distribution However, clinically significant infection is: Rare Isolation therefore requires interpretation in the context of the patient’s symptoms, specimen source, and underlying risk factors.

Opportunistic Infection Kluyvera behaves primarily as an opportunistic pathogen. Infection is more likely in patients with: • Immunosuppression

• Serious underlying illness

• Prolonged hospitalization

• Invasive devices

• Disruption of normal anatomic barriers Nevertheless, infections can occasionally occur in otherwise healthy individuals.

Bacteremia Kluyvera species can cause: Bacteremia Bloodstream infection may arise from another focus such as the: • Urinary tract

• Soft tissues

• Respiratory tract Severe cases may progress to systemic sepsis.

High-Yield Bacteremia Pattern Hospitalized or immunocompromised patient  ●  Unusual Enterobacterales isolated from blood  ●  Possible urinary or soft-tissue source → Consider Kluyvera species

Urinary Tract Infection Kluyvera species have been associated with: Urinary tract infections Clinical presentations may include: • Cystitis

• Pyelonephritis

• Complicated urinary infection

• Urosepsis Urine culture with susceptibility testing is important because antimicrobial resistance patterns may vary.

Soft-Tissue Infection The organisms can occasionally produce: Skin and soft-tissue infection Potential manifestations include: • Wound infection

• Cellulitis

• Abscess formation Management may require both appropriate antimicrobial therapy and source control, such as drainage or debridement when indicated.

Pneumonia The source particularly associates Kluyvera with: Pneumonia in immunosuppressed patients Respiratory isolation should be interpreted carefully because the clinical significance of an unusual Gram-negative organism depends on the specimen quality and evidence of true lower respiratory tract infection.

Diagnosis The primary diagnostic method is: Culture Depending on the clinical syndrome, specimens may include: • Blood

• Urine

• Respiratory specimens

• Wound material

• Abscess fluid

• Tissue specimens Species identification and antimicrobial susceptibility testing are particularly useful because Kluyvera infections are uncommon.

Antimicrobial Resistance Important Feature The source emphasizes that information about antimicrobial susceptibility is limited. Historically, Kluyvera species have demonstrated resistance to: • Ampicillin

• First-generation cephalosporins

• Second-generation cephalosporins Therefore, these agents should not automatically be assumed to provide reliable therapy.

Beta-Lactamase Significance A particularly important microbiologic feature is that some Kluyvera species possess chromosomal beta-lactamases. Kluyvera ascorbata is especially notable in antimicrobial-resistance microbiology because it has been recognized as a reservoir associated with the evolutionary origin of certain CTX-M-type extended-spectrum beta-lactamases (ESBLs). This makes Kluyvera important not only as a rare pathogen but also in the study of beta-lactam resistance genes.

Treatment The source states that several antimicrobial classes are usually active, including: • Third-generation cephalosporins

• Antipseudomonal agents

• Fluoroquinolones

• Aminoglycosides However, because susceptibility can vary, treatment should be based whenever possible on: Culture + susceptibility testing

Additional Treatment The source also lists: Chloramphenicol as an additional treatment option. This represents an older therapeutic option and is not generally a preferred routine treatment when safer active alternatives are available.

Treatment Principle Because Kluyvera infections are rare and resistance patterns can vary: Identify the organism ↓ Perform antimicrobial susceptibility testing ↓ Determine the infection site and severity ↓ Select an active antimicrobial ↓ Provide source control when necessary This approach is more useful than relying on a single standard regimen.

High-Yield Clinical Pattern Immunocompromised or hospitalized patient  ●  Bacteremia, UTI, soft-tissue infection, or pneumonia  ●  Uncommon Gram-negative bacillus  ●  Resistance to ampicillin/early-generation cephalosporins → Consider Kluyvera species

Resistance High-Yield Pattern Kluyvera ascorbata  ●  Chromosomal beta-lactamase  ●  Evolutionary reservoir associated with CTX-M-type ESBL genes → Important connection between Kluyvera and antimicrobial resistance

Kluyvera vs. Klebsiella Kluyvera → Rare opportunistic pathogen

→ Bacteremia, UTI, soft-tissue infection, pneumonia

→ Important beta-lactamase reservoir

→ Susceptibility-guided treatment Klebsiella → Much more common pathogen

→ Pneumonia, UTI, bacteremia

→ Prominent polysaccharide capsule

→ Nonmotile

→ ESBL and carbapenemase resistance are major clinical concerns

Exam Essentials Genus: Kluyvera

Important species: K. ascorbata, K. cryocrescens

Source correction: “K. cryorencens” → K. cryocrescens

Morphology: Gram-negative bacillus

Group: Enterobacterales

Distribution: Worldwide

Frequency: Rare human pathogen

Source of infection: Frequently endogenous/opportunistic

Major infections: Bacteremia, UTI, soft-tissue infection

Important host: Immunocompromised patients

Respiratory manifestation: Pneumonia

Diagnosis: Culture

Important resistance: Ampicillin and early-generation cephalosporins may be unreliable

Important microbiology association: K. ascorbata and CTX-M-type ESBL ancestry

Potential active agents in source: Third-generation cephalosporins, fluoroquinolones, antipseudomonal agents, aminoglycosides

Historical additional treatment: Chloramphenicol

Management principle: Susceptibility-guided antimicrobial therapy

Key clinical pearl: Kluyvera species are rare opportunistic Gram-negative bacilli that can cause bacteremia, UTI, soft-tissue infection, and pneumonia. K. ascorbata is especially notable because its chromosomal beta-lactamases are linked to the evolutionary origin of important CTX-M-type ESBL resistance determinants.